Back
Catalyst Pharmaceuticals Stock Price Chart
Free, 30-minute video on trading overnight options for big gains
Get access to this 30-minute training free here.
Sell
49
CPRX
Catalyst Pharmaceuticals
Last Price:
15.18
Seasonality Move:
34.21%
7 Day Trial
ALL ACCESS PASS
$
7
20 High-Yield Dividend Stocks that Could Ruin Your Retirement
Sign up now to get this report and avoid a high-yield dividend trap - Yours FREE.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing slight buying pressure.
Catalyst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.35 | Sell |
| 20-day SMA: | 15.37 | Sell |
| 50-day SMA: | 15.61 | Sell |
| 200-day SMA: | 14.66 | Buy |
| 8-day EMA: | 15.38 | Sell |
| 20-day EMA: | 15.45 | Sell |
| 50-day EMA: | 15.54 | Sell |
| 200-day EMA: | 14.98 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 44.66 | Sell |
| Chaikin Money Flow: | 44132 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.13 - 15.93) | Sell |
| Bollinger Bands (100): | (14.69 - 16.33) | Sell |
Catalyst Pharmaceuticals Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 15.19 while CPRX 8-day simple moving average is 15.35, which is a Sell signal.
- The stock price of CPRX is 15.19 while Catalyst Pharmaceuticals 20-day SMA is 15.37, which makes it a Sell.
- Catalyst Pharmaceuticals 50-day simple moving average is 15.61 while CPRX share price is 15.19, making it a Sell technically.
- CPRX stock price is 15.19 and Catalyst Pharmaceuticals 200-day simple moving average is 14.66, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Sell
49
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a Sell
The current Catalyst Pharmaceuticals [CPRX] share price is $15.19. The Score for CPRX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
1.79B
Price in USD:
15.19
Share Volume:
603.13K
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
17.50
52-Week Low:
11.55
Sell
49
Catalyst Pharmaceuticals (CPRX)
is a Sell
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?
The Catalyst Pharmaceuticals stock price is 15.19 USD today. -
Will CPRX stock go up or go down?
Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Catalyst Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 15.19 while CPRX 8-day exponential moving average is 15.38, which is a Sell signal.
- The stock price of CPRX is 15.19 while Catalyst Pharmaceuticals 20-day EMA is 15.45, which makes it a Sell.
- Catalyst Pharmaceuticals 50-day exponential moving average is 15.54 while CPRX share price is 15.19, making it a Sell technically.
- CPRX stock price is 15.19 and Catalyst Pharmaceuticals 200-day simple moving average is 14.98, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.14 per share, and an increase next year of $0.20 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
- CPRX Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Catalyst Pharmaceuticals is a Sell
- Catalyst Pharmaceuticals Relative Strength Index (RSI) is 44.66, which suggest Catalyst Pharmaceuticals is oversold
- The Bollinger Bands (25) for Catalyst Pharmaceuticals is (15.13 - 15.93), which suggest Catalyst Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Catalyst Pharmaceuticals is (14.69 - 16.33), which suggest Catalyst Pharmaceuticals is a Sell
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.